Rapid acceleration of diagnostics (RADX) tech

Ended Definitive Contract Awarded Last action

Contract number
75N92023C00002
Awardee
Awarding agency
Obligated
$1,056,295

Award facts

Contract value 100% obligated
$1,056,294.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 -$43,056
Original award $1,099,350

About this award

This is a $1,056,294.50 Firm Fixed Price definitive contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Rosalind, Inc., a self-certified small disadvantaged business. The contract is for the Rapid Acceleration of Diagnostics (RADX) Tech program and has an ultimate completion date of December 4, 2023. The contract was awarded on December 5, 2022 and does not have a set-aside designation.

Quick answers

Who was awarded contract 75N92023C00002?

75N92023C00002 was awarded to Rosalind, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on December 5, 2022.

How much is contract 75N92023C00002 worth?

The government has obligated $1,056,295 on 75N92023C00002.

Was contract 75N92023C00002 competed?

The extent of competition for 75N92023C00002 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award